Kosin Med J.  2019 Jun;34(1):24-29. 10.7180/kmj.2019.34.1.24.

The Effectiveness of Dexmedetomidine in Vacuum-Assisted Breast Biopsy Under Monitored Anesthesia Care

• Kim KW
• Park JH
• Kim S
• Ahn EJ
• Kim HJ
• Choi HR
• Chang YG
• Bang SR

• KMID: 2451772
• DOI: http://doi.org/10.7180/kmj.2019.34.1.24

Abstract

OBJECTIVES
Vacuum-assisted breast biopsy (VABB) is a widely used technique for the diagnosis of breast lesions. It is carried out with local anesthesia, but procedural pain and stress are still problematic. Dexmedetomidine is a α-2 receptor agonist that can sedate without significant respiratory depression. The study aimed to report the effectiveness of sedation with monitored anesthesia care (MAC) using dexmedetomidine in VABB.
METHODS
This was a retrospective chart review of patients who received VABB under MAC with dexmedetomidine. Forty-seven patients during the period of February 2015 to July 2016 were included. We collected data on patient characteristics, infusion drug and dose, induction to incision time, anesthetic, operation, and recovery time and other complications and vital signs.
RESULTS
The mean operating time was 50.1 ± 24.9 minutes, and the anesthetic time was 71.2 ± 28.3 minutes. The mean time from induction to incision was 17.0 ± 5.2 minutes, and the recovery time was 20.1 ± 10.3 minutes. None of the patients needed an advanced airway management. Further, none of them showed hemodynamic instability.
CONCLUSIONS
VABB was successfully performed with MAC using dexmedetomidine, and there was no respiratory depression or hemodynamic instability.

Keyword

Dexmedetomidine; Mammotome; Monitored anesthesia care; Vacuum-assisted breast biopsy

MeSH Terms

Airway Management
Anesthesia*
Anesthesia, Local
Biopsy*
Breast*
Dexmedetomidine*
Diagnosis
Hemodynamics
Humans
Respiratory Insufficiency
Retrospective Studies
Vital Signs
Dexmedetomidine

Reference

1. Ding B, Chen D, Li X, Zhang H, Zhao Y. Meta analysis of efficacy and safety between Mammotome vacuum-assisted breast biopsy and open excision for benign breast tumor. Gland Surg. 2013; 2:69–79.

2. Hoorntje LE, Peeters PH, Mali WP, Borel Rinkes IH. Vacuum-assisted breast biopsy: a critical review. Eur J Cancer. 2003; 39:1676–1683.

3. Zagouri F, Sergentanis TN, Gounaris A, Koulocheri D, Nonni A, Domeyer P, et al. Pain in different methods of breast biopsy: emphasis on vacuum-assisted breast biopsy. Breast. 2008; 17:71–75.

4. Zografos GC, Zagouri F, Sergentanis TN, Nonni A, Domeyer P, Koulocheri D, et al. Pain during vacuum-assisted breast biopsy: are there any predictors? Breast. 2008; 17:592–595.

5. Eller A, Janka R, Lux M, Saake M, Schulz-Wendtland R, Uder M, et al. Stereotactic vacuum-assisted breast biopsy (VABB)--a patients' survey. Anticancer Res. 2014; 34:3831–3837.

6. Gounaris A, Zagouri F, Sergentanis TN, Provatopoulou X, Kalogera E, Sagkriotis A, et al. Vacuum-assisted Breast Biopsy: Insight into Stress-induced Endocrine Events. In Vivo. 2007; 21:1081–1084.

7. ASA. Position on monitored anesthesia care. Cited 2013 Oct 16. Available from: http://www.asahq.org/~/media/sites/asahq/files/public/resources/standards-guidelines/position-on-monitored-anesthesia-care/.

8. Rasheed MA, Punera DC, Bano M, Palaria U, Tyagi A, Sharma S. A study to compare the overall effectiveness between midazolam and dexmedetomidine during monitored anesthesia care: A randomized prospective study. Anesth Essays Res. 2015; 9:167–172.

9. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000; 90:699–705.

10. Surana P, Parikh DA, Patkar GA, Tendolkar BA. A prospective randomized controlled double-blind trial to assess the effects of dexmedetomidine during cleft palate surgery. Korean J Anesthesiol. 2017; 70:633–641.

11. Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg. 2002; 95:461–466.

12. Park HL, Hong J. Vacuum-assisted breast biopsy for breast cancer. Gland Surg. 2014; 3:120–127.

13. Rageth CJ, O'Flynn EA, Comstock C, Kurtz C, Kubik R, Madjar H, et al. First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat. 2016; 159:203–213.

14. Bennett IC. The Changing Role of Vacuum-assisted Biopsy of the Breast: A New Prototype of Minimally Invasive Breast Surgery. Clin Breast Cancer. 2017; 17:323–325.